Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
EDMONTON, Alberta, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of...
-
EDMONTON, Alberta, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of...
-
- New Edmonton-based facility fully commissioned and first orders shipped - Filed for a Drug Establishment License from Health Canada to allow the Company to handle biopharmaceuticals products ...
-
Ceapro Inc. Receives the 2018 Award for Most Innovative Raw Material at Cosmetics 360 Salon in Paris
New chemical complex, beta glucan-Co enzyme Q10, attracts special attention as a potentially strong antioxidant to be incorporated in a new formulation from Company’s proprietary cosmeceutical...
-
– Ceapro is Pioneering approach with a natural product as add-on therapy to a prescription product – First of the clinical studies being conducted as part of collaboration with the Montreal Heart...
-
EDMONTON, Alberta, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of...
-
EDMONTON, Alberta, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V:CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of...
-
EDMONTON, Alberta, June 27, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSXV:CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of...
-
EDMONTON, Alberta, June 13, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V:CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of...
-
EDMONTON, Alberta, June 05, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V:CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of...